PINK1 protein in normal human brain and Parkinson's disease

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in <i>PINK1</i>

Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · see citing works

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859 · see citing works

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,800 · see citing works

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

Tmbase-A database of membrane spanning protein segments

Hofmann, K., & Stoffel, W. (1993) · Medical Entomology and Zoology · Cited by 2,257 · see citing works

Oxidative stress in neurodegeneration: Cause or consequence?

Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869 · see citing works

The ubiquitin pathway in Parkinson's disease

Leroy, E., Boyer, R., Auburger, G. W. J., Leube, B., Ulm, G., Mezey, É., Harta, G., Brownstein, M., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,572 · see citing works

Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease

HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542 · see citing works

[31] PHD: Predicting one-dimensional protein structure by profile-based neural networks

Rost, B. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)66033-9 · Cited by 1,282 · see citing works

Mitochondrial pathology and apoptotic muscle degeneration in <i>Drosophila parkin</i> mutants

Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203 · see citing works

The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization

Canet-Aviles, R., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,115 · see citing works

Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease

(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

McKeith, I. G. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s347 · Cited by 625 · see citing works

Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein

Fornai, F., Schlüter, O. M., Lenzi, P., Gesi, M., Ruffoli, R., Ferrucci, M., Lazzeri, G., Busceti, C. L., Pontarelli, F., Battaglia, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409713102 · Cited by 526 · see citing works

PINK1 mutations are associated with sporadic early‐onset parkinsonism

Valente, E. M., Salvi, S., Ialongo, T., Marongiu, R., Elia, A. E., Caputo, V., Romito, L. M., Albanese, A., Dallapiccola, B., & Bentivoglio, A. R. (2004) · Annals of Neurology · doi:10.1002/ana.20256 · Cited by 506 · see citing works

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease

Bandopadhyay, R. (2004) · Brain · doi:10.1093/brain/awh054 · Cited by 466 · see citing works

Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism

Silvestri, L., Caputo, V., Bellacchio, E., Atorino, L., Dallapiccola, B., Valente, E. M., & Casari, G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi377 · Cited by 449 · see citing works

Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway

Unoki, M., & Nakamura, Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204608 · Cited by 382 · see citing works

Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability

Beilina, A. G., van der Brug, M., Ahmad, R., Kesavapany, S., Miller, D. W., Petsko, G. A., & Cookson, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500617102 · Cited by 382 · see citing works

Polypeptide and phospholipid composition of the membrane of rat liver peroxisomes: comparison with endoplasmic reticulum and mitochondrial membranes.

Fujiki, Y., Fowler, S., Shio, H., Hubbard, A. L., & Lazarow, P. B. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.93.1.103 · Cited by 373 · see citing works

Early-onset parkinsonism associated with PINK1 mutations

Bonifati, V., Rohé, C. F., Breedveld, G. J., Fabrizio, E., Mari, M. D., Tassorelli, C., Tavella, A., Marconi, R., Nicholl, D. J., Chien, H. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167546.39375.82 · Cited by 338 · see citing works

Wild-type PINK1 Prevents Basal and Induced Neuronal Apoptosis, a Protective Effect Abrogated by Parkinson Disease-related Mutations

Petit-Paitel, A., Kawarai, T., Paitel, E., Sanjo, N., Maj, M. C., Scheid, M. P., Chen, F., Gu, Y., Hasegawa, H., Salehi‐Rad, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505143200 · Cited by 329 · see citing works

Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies

Schlossmacher, M. G., Frosch, M. P., Gai, W., Medina, M., Sharma, N., Forno, L. S., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61113-3 · Cited by 324 · see citing works

[6] Preparation of synaptic and nonsynaptic mitochondria from mammalian brain

Lai, J. C. K., & Clark, J. B. (1979) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(79)55008-3 · Cited by 297 · see citing works

Novel PINK1 mutations in early-onset parkinsonism

波田野, 靖. (2005) · Medical Entomology and Zoology · Cited by 227 · see citing works

Epitope Mapping by Label-Free Biomolecular Interaction Analysis

Malmqvist, M. (1996) · Methods · doi:10.1006/meth.1996.0060 · Cited by 223 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

Psych, M. R. C. (1996) · Cited by 202 · see citing works

Analysis of the PINK1 Gene in a Large Cohort of Cases With Parkinson Disease

Rogaeva, E. A., Johnson, J. O., Lang, A. E., Gulick, C., Gwinn, K. A., Kawarai, T., Sato, C., Morgan, A. R., Werner, J. S., Nussbaum, R. L., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1898 · Cited by 199 · see citing works

Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET study

Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A., Brooks, D. J., & Piccini, P. P. (2002) · Annals of Neurology · doi:10.1002/ana.10417 · Cited by 199 · see citing works

Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies

Ferrer, I., Blanco, R. E., Carmona, M., Puig, B., Barrachina, M., Gómez, C., & Ambrosio, S. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100015 · Cited by 172 · see citing works

Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism

Li, Y., Tomiyama, H., Sato, K., Hatano, Y., Yoshino, H., Atsumi, M., Kitaguchi, M., Sasaki, S., Kawaguchi, S., Miyajima, H., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000164009.36740.4e · Cited by 138 · see citing works

Amyloid accomplices and enforcers

Alexandrescu, A. T. (2004) · Protein Science · doi:10.1110/ps.04887005 · Cited by 134 · see citing works

Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism

Rohé, C. F., Montagna, P., Breedveld, G. J., Cortelli, P., Oostra, B. A., & Bonifati, V. (2004) · Annals of Neurology · doi:10.1002/ana.20247 · Cited by 126 · see citing works

Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.

Brion, J., & Couck, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 125 · see citing works

Heterogeneity of Nigral and Cortical Lewy Bodies Differentiated by Amplified Triple-Labeling for Alpha-Synuclein, Ubiquitin, and Thiazin Red

Sakamoto, M., Uchihara, T., Hayashi, M., Nakamura, A., Kikuchi, E., Mizutani, T., Mizusawa, H., & Hirai, S. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7961 · Cited by 47 · see citing works

Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene‐related dementias: a morphological study

Lashley, T., Holton, J. L., Verbeek, M. M., Rostagno, A. A., Bojsen‐Møller, M., David, G., van Horssen, J., Brændgaard, H., Plant, G. T., Frangione, B., et al. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00747.x · Cited by 33 · see citing works

Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism

李, 元. (2008) · Cited by 33 · see citing works

[26] Mitochondrial ATP-dependent protease from rat liver and yeast

Kuzela, S., & Goldberg, A. L. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)44028-x · Cited by 19 · see citing works

Electron-microscopic observation of the nucleus basilis of Meynert in human autopsy cases

Morimura, Y., Hirano, A., & Llena, J. F. (1985) · Acta Neuropathologica · doi:10.1007/bf00688634 · Cited by 5 · see citing works

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

Subramaniam, S., & Chesselet, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 925 · see citing works

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883 · see citing works

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 786 · see citing works

Parkinson's disease

Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748 · see citing works

<i>Drosophila</i> Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin

Ziviani, E., Tao, R. N., & Whitworth, A. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913485107 · Cited by 735 · see citing works

Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress

Gautier, C. A., Kitada, T., & Shen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802076105 · Cited by 698 · see citing works

Mitochondrial dysfunction in Parkinson's disease

Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688 · see citing works

The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila

Deng, H., Dodson, M. W., Huang, H., & Guo, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803998105 · Cited by 683 · see citing works

PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death

Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.013 · Cited by 682 · see citing works

What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease

Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 610 · see citing works

PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1

Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050172 · Cited by 596 · see citing works

Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention

Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.004 · Cited by 580 · see citing works

The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates

Wakabayashi, K., Tanji, K., Mori, F., & Takahashi, H. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00803.x · Cited by 516 · see citing works

Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin

Exner, N., Treske, B., Paquet, D., Holmström, K. M., Schiesling, C., Gispert, S., Carballo‐Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 511 · see citing works

PINK1 cleavage at position A103 by the mitochondrial protease PARL

Deas, E., Plun‐Favreau, H., Gandhi, S., Desmond, H., Kjaer, S., Loh, S. H. Y., Renton, A. E., Harvey, R. J., Whitworth, A. J., Martins, L. M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq526 · Cited by 501 · see citing works

The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders

Wakabayashi, K., Tanji, K., Odagiri, S., Miki, Y., Mori, F., & Takahashi, H. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8280-y · Cited by 478 · see citing works

The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1

Plun‐Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R. J., McDonald, N. Q., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1644 · Cited by 476 · see citing works

Glia: Initiators and progressors of pathology in Parkinson's disease

Halliday, G. M., & Stevens, C. H. (2011) · Movement Disorders · doi:10.1002/mds.23455 · Cited by 423 · see citing works

Mitochondrial Diseases of the Brain

Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 416 · see citing works

Histone deacetylase 6 interacts with the microtubule‐associated protein tau

Ding, H., Dolan, P. J., & Johnson, G. V. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05564.x · Cited by 387 · see citing works

The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking

Meißner, C., Lorenz, H., Weihofen, A., Selkoe, D. J., & Lemberg, M. K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07253.x · Cited by 375 · see citing works

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Norat, P., Soldozy, S., Sokolowski, J. D., Gorick, C. M., Kumar, J. S., Chae, Y., Yağmurlu, K., Prada, F. U., Walker, M., Levitt, M. R., et al. (2020) · npj Regenerative Medicine · doi:10.1038/s41536-020-00107-x · Cited by 353 · see citing works

Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature

Schneider, S. A., & Alcalay, R. N. (2017) · Movement Disorders · doi:10.1002/mds.27193 · Cited by 341 · see citing works

Understanding the molecular causes of Parkinson's disease

Wood‐Kaczmar, A., Gandhi, S., & Wood, N. W. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.09.007 · Cited by 327 · see citing works

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons

Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. S. Y., Miljan, E. A., Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., Deas, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002455 · Cited by 316 · see citing works

The kinase domain of mitochondrial PINK1 faces the cytoplasm

Zhou, C. H., Huang, Y., Shao, Y., May, J., Prou, D., Perier, C., Dauer, W. T., Schon, E. A., & Przedborski, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802814105 · Cited by 312 · see citing works

The Genetics of Parkinson Disease

Bekris, L. M., Mata, I. F., & Zabetian, C. P. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383572 · Cited by 307 · see citing works

The neuropathology of genetic Parkinson's disease

Poulopoulos, M., Levy, O. A., & Alcalay, R. N. (2012) · Movement Disorders · doi:10.1002/mds.24962 · Cited by 306 · see citing works

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

Klein, C., Lohmann-Hedrich, K., Rogaeva, E. A., Schlossmacher, M. G., & Lang, A. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70174-6 · Cited by 304 · see citing works

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288 · see citing works

Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease

Dodson, M. W., & Guo, M. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.04.010 · Cited by 277 · see citing works

Characterization of PINK1 processing, stability, and subcellular localization

Lin, W., & Kang, U. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05398.x · Cited by 261 · see citing works

PINK1-linked parkinsonism is associated with Lewy body pathology

Samaranch, L., Lorenzo‐Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., et al. (2010) · Brain · doi:10.1093/brain/awq051 · Cited by 256 · see citing works

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.007 · Cited by 256 · see citing works

Impairing the Mitochondrial Fission and Fusion Balance: A New Mechanism of Neurodegeneration

Knott, A. B., & Bossy‐Wetzel, E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.030 · Cited by 258 · see citing works

Degeneration in Different Parkinsonian Syndromes Relates to Astrocyte Type and Astrocyte Protein Expression

Song, Y. J. C., Halliday, G. M., Holton, J. L., Lashley, T., O’Sullivan, S. S., McCann, H., Lees, A. J., Ozawa, T., Williams, D. R., Lockhart, P. J., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b66f1b · Cited by 239 · see citing works

Pathogenic mutations in Parkinson disease

Tan, E., & Skipper, L. M. (2007) · Human Mutation · doi:10.1002/humu.20507 · Cited by 221 · see citing works

The genetics of Parkinson's syndromes: a critical review

Hardy, J., Lewis, P. A., Révész, T., Lees, A. J., & Paisán‐Ruiz, C. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.03.008 · Cited by 210 · see citing works

Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder

Klein, C., & Schlossmacher, M. G. (2007) · Neurology · doi:10.1212/01.wnl.0000271880.27321.a7 · Cited by 209 · see citing works

Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6

Hoepken, H.-H., Gispert, S., Morales, B., Wingerter, O., Turco, D. D., Mülsch, A., Nussbaum, R. L., Müller, K., Dröse, S., Brandt, U., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.007 · Cited by 202 · see citing works

Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells

Gegg, M. E., Cooper, J. M., Schapira, A. H. V., & Taanman, J.-W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004756 · Cited by 198 · see citing works

Antioxidants protect PINK1 -dependent dopaminergic neurons in Drosophila

Wang, D., Li, Q., Xiong, H., Liu, J., Neckameyer, W. S., Oldham, S., Xia, K., Wang, J., Bodmer, R., & Zhang, Z. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604661103 · Cited by 196 · see citing works

The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease

Zuo, L., & Motherwell, M. S. (2013) · Gene · doi:10.1016/j.gene.2013.07.085 · Cited by 194 · see citing works

Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth

Sämann, J., Hegermann, J., von Gromoff, E. D., Eimer, S., Baumeister, R., & Schmidt, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808255200 · Cited by 192 · see citing works

Mitochondrial DNA damage and repair in neurodegenerative disorders

Yang, J., Weissman, L., Bohr, V. A., & Mattson, M. P. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.03.012 · Cited by 185 · see citing works

Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells

Tran, J., Anastacio, H. T. D., & Bardy, C. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-0110-8 · Cited by 181 · see citing works

Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF- B signaling

Sha, D., Chin, L., & Li, L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp501 · Cited by 180 · see citing works

Loss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish

Anichtchik, O. V., Diekmann, H., Fleming, A., Roach, A. G., Goldsmith, P., & Rubinsztein, D. C. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0979-08.2008 · Cited by 178 · see citing works

Mitochondrial Dysfunction in Parkinson's Disease

Keane, P. C., Kurzawa‐Akanbi, M., Blain, P. G., & Morris, C. M. (2011) · Parkinson s Disease · doi:10.4061/2011/716871 · Cited by 177 · see citing works

A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases

Mandemakers, W. J., Morais, V. A., & Strooper, B. D. (2007) · Journal of Cell Science · doi:10.1242/jcs.03443 · Cited by 176 · see citing works

Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress

Muqit, M. M. K., Abou‐Sleiman, P. M., Saurin, A. T., Harvey, K., Gandhi, S., Deas, E., Eaton, S. D., Smith, M. D. P., Venner, K., Matilla‐Dueñas, A., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03845.x · Cited by 172 · see citing works

Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease

Shi, G. W., Lee, J. R., Grimes, D. A., Racacho, L., Ye, D., Yang, H. H., Ross, O. A., Farrer, M. J., McQuibban, G. A., & Bulman, D. E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr077 · Cited by 169 · see citing works

Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1

Weihofen, A., Ostaszewski, B. L., Minami, Y., & Selkoe, D. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm334 · Cited by 167 · see citing works

A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease

Chu, C. T. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq143 · Cited by 167 · see citing works

Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse

Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.042 · Cited by 165 · see citing works

miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)

Kim, J., Fiesel, F. C., Belmonte, K. C., Hudec, R., Wang, W.-X., Kim, C., Nelson, P. T., Springer, W., & Kim, J. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0121-4 · Cited by 163 · see citing works

Astrocytic Oxidative/Nitrosative Stress Contributes to Parkinson’s Disease Pathogenesis: The Dual Role of Reactive Astrocytes

Rizor, A., Pajarillo, E. A. B., Johnson, J., Aschner, M., & Lee, E.-S. (2019) · Antioxidants · doi:10.3390/antiox8080265 · Cited by 159 · see citing works

Genetic basis of Parkinson's disease: inheritance, penetrance, and expression

Gasser, T. (2011) · The Application of Clinical Genetics · doi:10.2147/tacg.s11639 · Cited by 158 · see citing works

PINK1 function in health and disease

Deas, E., Plun‐Favreau, H., & Wood, N. W. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900024 · Cited by 154 · see citing works

C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1

Sim, C. H., Lio, D. S. S., Mok, S. S., Masters, C. L., Hill, A. F., Culvenor, J. G., & Cheng, H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl398 · Cited by 146 · see citing works

The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson’s Disease

Lin, K.-J., Lin, K.-L., Chen, S., Liou, C., Chuang, Y., Lin, H., & Lin, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215312 · Cited by 141 · see citing works

The role of mitochondria in neurodegenerative diseases

Filosto, M., Scarpelli, M., Cotelli, M. S., Vielmi, V., Todeschini, A., Gregorelli, V., Tonin, P., Tomelleri, G., & Padovani, A. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6104-z · Cited by 140 · see citing works

Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases

Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 139 · see citing works

Mitochondrial dynamics in Parkinson's disease

Laar, V. S. V., & Berman, S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.019 · Cited by 139 · see citing works

The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function

Scheele, C. C., Petrovič, N., Faghihi, M. A., Lassmann, T., Fredriksson, K., Rooyackers, O., Wahlestedt, C., Good, L., & Timmons, J. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-74 · Cited by 137 · see citing works

The PINK1/Parkin pathway: a mitochondrial quality control system?

Whitworth, A. J., & Pallanck, L. J. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9253-3 · Cited by 136 · see citing works

Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease

Schiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00952.x · Cited by 135 · see citing works

Mitochondrial alterations in Parkinson’s disease: new clues

Vila, M., Ramonet, D., & Perier, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05604.x · Cited by 131 · see citing works

Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration

Croisier, E., & Graeber, M. B. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0119-z · Cited by 130 · see citing works

PINK1-Parkin Pathway Activity Is Regulated by Degradation of PINK1 in the Mitochondrial Matrix

Thomas, R. E., Andrews, L. A., Burman, J. L., Lin, W.-Y., & Pallanck, L. J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004279 · Cited by 129 · see citing works

Unconventional PINK1 localization mechanism to the outer membrane of depolarized mitochondria drives Parkin recruitment

Okatsu, K., Kimura, M., Oka, T., Tanaka, K., & Matsuda, N. (2015) · Journal of Cell Science · doi:10.1242/jcs.161000 · Cited by 127 · see citing works

PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons

Wang, H., Chou, A.-H., Wu, A.-S., Chen, S.-Y., Weng, Y.-H., Kao, Y.-C., Yeh, T., Chu, P., & Lu, C.-S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.007 · Cited by 121 · see citing works

Beyond the mitochondrion: cytosolic PINK 1 remodels dendrites through Protein Kinase A

Dagda, R. K., Pien, I., Wang, R., Zhu, J., Wang, K. Z. Q., Callio, J., Banerjee, T. D., Dagda, R. Y., & Chu, C. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12494 · Cited by 120 · see citing works

Calcium signaling in Parkinson’s disease

Calí, T., Ottolini, D., & Brini, M. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1866-0 · Cited by 119 · see citing works

Molecular Pathology of Lewy Body Diseases

Beyer, K., Domingo-Sàbat, M., & Ariza, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030724 · Cited by 119 · see citing works

Autophagy-related proteins are functionally active in human spermatozoa and may be involved in the regulation of cell survival and motility

Aparicio, I. M., Espino, J., Bejarano, I., Gallardo, A., Campo, M. L., Salido, G. M., Pariente, J. A., Peña, F. J., & Tapia, J. A. (2016) · Scientific Reports · doi:10.1038/srep33647 · Cited by 119 · see citing works

Protein Misfolding and Aggregation in Parkinson's Disease

Tan, J. M. M., Wong, E. S. P., & Lim, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2490 · Cited by 119 · see citing works

Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1

Takatori, S., Ito, G., & Iwatsubo, T. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.019 · Cited by 119 · see citing works

Etiology and Pathogenesis of Parkinson Disease

Schapira, A. H. V. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.04.004 · Cited by 118 · see citing works

Kinases and kinase signaling pathways: Potential therapeutic targets in Parkinson's disease

Wang, G., Pan, J., & Chen, S. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.003 · Cited by 116 · see citing works

A critical evaluation of the ubiquitin–proteasome system in Parkinson's disease

Cook, C. N., & Petrucelli, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.012 · Cited by 112 · see citing works

Mitochondria Dysfunction and Neurodegenerative Disorders: Cause or Consequence

Morais, V. A., & Strooper, B. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100345 · Cited by 111 · see citing works

Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?

Scheele, C., Nielsen, A. R., Walden, T. B., Sewell, D. A., Fischer, C. P., Brogan, R. J., Petrovic, N., Larsson, O., Tesch, P. A., Wennmalm, K., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8520com · Cited by 110 · see citing works

Impact of recent genetic findings in Parkinson??s disease

Klein, C., & Lohmann-Hedrich, K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281e6692b · Cited by 109 · see citing works

Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse

Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.569 · Cited by 108 · see citing works

Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation

Piccoli, C., Sardanelli, A. M., Scrima, R., Ripoli, M. C., Quarato, G., D’Aprile, A., Bellomo, F., Scacco, S., Michele, G. D., Filla, A., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9729-2 · Cited by 105 · see citing works

Pathological Functions of LRRK2 in Parkinson’s Disease

Jeong, G. R., & Lee, B. D. (2020) · Cells · doi:10.3390/cells9122565 · Cited by 105 · see citing works

Reduction of Protein Translation and Activation of Autophagy Protect against PINK1 Pathogenesis in Drosophila melanogaster

Liu, S., & Lu, B. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001237 · Cited by 104 · see citing works

DJ-1 facilitates the interaction between STAT1 and its phosphatase, SHP-1, in brain microglia and astrocytes: A novel anti-inflammatory function of DJ-1

Kim, J.-H., Choi, D.-J., Jeong, H.-K., Kim, J., Kim, D. W., Choi, S. Y., Park, S.-M., Suh, Y. H., Jou, I., & Joe, E.-H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.007 · Cited by 102 · see citing works

Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease

Hatano, T., Kubo, S., Sato, S., & Hattori, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06403.x · Cited by 98 · see citing works

The roles of non-coding RNAs in Parkinson’s disease

Majidinia, M., Mihanfar, A., Rahbarghazi‬, R., Nourazarian, A., Bağca, B. G., & Avcı, Ç. B. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-4054-3 · Cited by 96 · see citing works

Parallel High-Throughput RNA Interference Screens Identify PINK1 as a Potential Therapeutic Target for the Treatment of DNA Mismatch Repair–Deficient Cancers

Martin, S. A., Hewish, M., Sims, D., Lord, C. J., & Ashworth, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2836 · Cited by 93 · see citing works

Biochemical aspects of the neuroprotective mechanism of PTEN‐induced kinase‐1 (PINK1)

Mills, R. D., Sim, C. H., Mok, S. S., Mulhern, T. D., Culvenor, J. G., & Cheng, H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05249.x · Cited by 93 · see citing works

Early Expression of Parkinson’s Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats

Villeneuve, L. M., Purnell, P. R., Boska, M. D., & Fox, H. S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8927-y · Cited by 92 · see citing works

Pink1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced akt and increased p38 mapk activation, and downregulation of egfr

Choi, I., Kim, J., Jeong, H., Kim, B., Jou, I., Park, S. M., Chen, L.-N., Kang, U. J., Zhuang, X., & Joe, E.-H. (2013) · Glia · doi:10.1002/glia.22475 · Cited by 88 · see citing works

TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency

Flinn, L. J., Keatinge, M., Bretaud, S., Mortiboys, H., Matsui, H., Felice, E. D., Woodroof, H. I., Brown, L., McTighe, A., Soellner, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23999 · Cited by 88 · see citing works

Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish

Sallinen, V. J., Kolehmainen, J., Priyadarshini, M., Toleikyte, G., Chen, Y., & Panula, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.001 · Cited by 87 · see citing works

PINK1 mutants associated with recessive Parkinson’s disease are defective in inhibiting mitochondrial release of cytochrome c

Wang, H., Chou, A.-H., Yeh, T., Li, A. H.-L., Chen, Y., Kuo, Y.-L., Tsai, S.-R., & Yu, S.-T. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.010 · Cited by 87 · see citing works

Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?

Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 86 · see citing works

Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease

Büeler, H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0465-0 · Cited by 85 · see citing works

Parkinson's disease

Révész, T., Gray, F., & Scaravilli, F. (2001) · Cited by 1 · see citing works

Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism

Silvestri, L., Caputo, V., Bellacchio, E., Atorino, L., Dallapiccola, B., Valente, E. M., & Casari, G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi377 · Cited by 449 · see citing works

Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease

Triplett, J. C., Zhang, Z., Sultana, R., Cai, J., Klein, J. B., Büeler, H., & Butterfield, D. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13039 · Cited by 58 · see citing works

Neonatal mitochondrial abnormalities due to PINK1 deficiency: Proteomics reveals early changes relevant to Parkinson׳s disease

Villeneuve, L. M., Purnell, P. R., Stauch, K. L., & Fox, H. S. (2015) · Data in Brief · doi:10.1016/j.dib.2015.11.070 · Cited by 9 · see citing works

[Molecular genetics of PINK1].

Funayama, M., & Hattori, N. (2007) · PubMed · Cited by 3 · see citing works